比特幣以太幣美國國債貨幣市場
slideslide

Bosera SZSE ChiNext Daily (2x) Leveraged Product (HKD Counter:7234)

​Important Information

    IMPORTANT: Investment involves risks. Investment value may rise or fall. Past performance information presented is not indicative of future performance. Investors should refer to the Prospectus and the Product Key Facts Statement for further details, including product features and risk factors. Investors should not base on this material alone to make investment decisions.      
Bosera SZSE ChiNext Daily (2x) Leveraged Product (the “Product”) is a sub-fund of Bosera Leveraged and Inverse Series, an umbrella unit trust established under Hong Kong law. Unit of Product (the “Units”) are traded in HKD on the Stock Exchange of Hong Kong Limited (the “SEHK”) like stocks. It is a swap-based product with an investment objective to provide Daily investment results, before fees and expenses, which closely correspond to twice (2x) the Daily performance of the ChiNext Index (“Index”). It is denominated in HKD. Creations and redemptions are in HKD only.

  • The Product is a derivative product and is not suitable for all investors. There is no guarantee of the repayment of principal. Therefore, your investment in the Product may suffer substantial or total losses.

  • The Product will utilise leverage to achieve a Daily return equivalent to twice (2x) the return of the Index. Both gains and losses will be magnified. The risk of loss resulting from an investment in the Product in certain circumstances including a bear market will be substantially more than a fund that does not employ leverage.

  • The Product is not intended for holding longer than one day as the performance of the Product over a period longer than one day will very likely differ in amount and possibly direction from the leveraged performance of the Index over that same period (e.g. the loss may be more than twice the fall in the Index). The effect of compounding becomes more pronounced on the Product’s performance as the Index experiences volatility. With higher Index volatility, the deviation of the Product’s performance from the leveraged performance of the Index will increase, and the performance of the Product will generally be adversely affected. As a result of Daily rebalancing, the Index’s volatility and the effects of compounding of each day’s return over time, it is even possible that the Product will lose money over time while the Index’s performance increases or is flat.

  • The Product may suffer significant losses if the Swap Counterparty fails to perform its obligations under the Swap. The value of the collateral assets may be affected by market events and may diverge substantially from the leveraged performance of the Index, which may cause the Product’s exposure to the Swap Counterparty to be under-collateralised and therefore result in significant losses.

  • The Product seeks to obtain the required exposure through more than one Swap with more than one Swap Counterparty. The Product is therefore exposed to counterparty risk and default risk of the Swap Counterparties and may suffer significant losses if a swap counterparty fails to perform its obligations. Derivative instruments are susceptible to price fluctuations and higher volatility, which may result in large bid and offer spreads with no active secondary market. The Product may suffer losses potentially equal to the full value of the financial derivatives.

  • In some circumstances, a Swap Counterparty can terminate the swap agreements early which may adversely impact the Product’s performance. Such early termination can also impair the Product’s ability to achieve its investment objective and may subject the Product to substantial loss. Also, the Product may face an increase in the cost to enter into a similar swap agreement with additional Swap Counterpart(ies).

  • The Product will bear the swap fees, which are subject to the discussion and consensus between the Manager and the Swap Counterparty based on the actual market circumstances on a case-by-case basis. The current swap fees are a best estimate only and may deviate from the actual market conditions. In extreme market conditions and exceptional circumstances, the Swap Counterparty’s costs of financing the underlying hedge may increase significantly and in return increase the swap fees.

  • There is no assurance that the Product can rebalance its portfolio on a Daily basis to achieve its investment objective. Market disruption, regulatory restrictions or extreme market volatility may adversely affect the Product’s ability to rebalance its portfolio.

  • The rebalancing activities of the Product typically take place near the end of trading of the underlying A-Share market to minimise tracking difference. As a result, the Product may be more exposed to the market conditions during a shorter interval and may be more subject to liquidity risk.

  • The Product is normally rebalanced at or around the close of trading of the underlying A-Share market on each Business Day. As such, return for investors that invest for period less than a full trading day will generally be greater than or less than two times (2x) the leveraged investment exposure to the Index, depending upon the movement of the Index from the end of one trading day until the time of purchase.

  • The Index constituents are companies listed on the Shenzhen Stock Exchange which is an emerging market. Investments of the Product may involve increased risks and special considerations not typically associated with an investment in more developed markets, such as liquidity risks, currency risks/control, political and economic uncertainties, legal and taxation risks, settlement risks, custody risk and the likelihood of a high degree of volatility. The A-Share market in the PRC is highly volatile and may be subject to potential settlement difficulties.  Prices of A-Shares may rise and fall significantly and may fluctuate to a greater degree than more developed markets.  Such volatility may result in suspension of A-Shares or imposition of other measures by the PRC authorities affecting the value of the Product. Securities exchanges in the PRC typically have the right to suspend or limit trading in any security traded on the relevant exchange. The government or the regulators may also implement policies that may affect the financial markets.  All these may have a negative impact on the Product.

  • The Index consists of A-Shares which may only be bought or sold from time to time where the relevant A-Shares may be sold or purchased on the Shenzhen Stock Exchange. Given that the A-Share market is considered volatile and unstable (with the risk of suspension of a particular stock or government intervention), such high market volatility and potential settlement difficulties in the A-Share market may result in significant fluctuations in the prices of the securities traded on the A-Share market and thereby may adversely affect the Product.

  • Any depreciation of RMB could adversely affect the value of investor’s investment in the Product. Although offshore RMB (CNH) and onshore RMB (CNY) are the same currency, they trade at different rates. Any divergence between CNH and CNY may adversely impact investors. The Product may need to use currency other than the base currency as set out in the relevant ISDA Credit Support Annex for collateral and Initial Amount posting purpose. The Product may enter into currency contract to hedge the currency risk but the currency exposure is linked to marked-to-market value of the Swaps. This may bring additional cost and currency risk for the Product.

  • The Product’s investments are concentrated in a specific geographical location (i.e. the PRC).  The value of the Product may be more volatile than that of a fund having a more diverse portfolio of investments.  The value of the Product may be more susceptible to adverse economic, political, policy, foreign exchange, liquidity, tax, legal or regulatory event affecting the PRC market.

  • Payment of distributions out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any capital gains attributable to that original investment and may result in an immediate reduction in the NAV per Unit.

  • The Product is not “actively managed” and the Manager will not adopt any temporary defensive position when the Index moves in an unfavourable direction. In such circumstances, Units of the Product will also decrease in value.

  • The trading price of the Units on the SEHK is driven by market factors such as the demand and supply of the Units. The Units may trade at a substantial premium or discount to the NAV.

  • As investors will pay certain charges (e.g. trading fees and brokerage fees) to buy or sell Units on the SEHK, investors may pay more than the NAV per Unit when buying Units on the SEHK, and may receive less than the NAV per Unit when selling Units on the SEHK.

  • The Product may invest in other collective investment schemes through the Manager’s QFII/RQFII status. The Product’s ability to achieve its investment objective and strategy may be affected by the applicable laws, rules and regulations (including restrictions on investments and repatriation of principal and profits) in the PRC mainland, which are subject to change and such change may have potential retrospective effect. The Swap Counterparties may hedge their Swap exposure by investing in A-Shares through QFII/ RQFII of itself or a third party/affiliate. If a Swap Counterparty for whatever reason is unable to trade through QFII or RQFII (for example, due to revocation, termination or invalidation of approval of the QFII / RQFII), this may hinder the Swap Counterparty’s ability to increase the size of the relevant Swap, which will in turn affect the Product’s ability to achieve its investment objective and strategy.  If this happens in respect of all the Swap Counterparties, the Product may be closed for subscriptions. This may also cause the Units to trade at a premium to their NAV. In the worst case scenario, the Product may be terminated.

  • Although the Manager will use its best endeavours to put in place arrangements so that at least one market maker will maintain a market for the Units and gives not less than three months’ notice prior to termination of the market making arrangement, liquidity in the market for the Units may be adversely affected if there is only one market maker for the Units. There is also no guarantee that any market making activity will be effective.

  • The Product may be subject to tracking error risk, which is the risk that its Daily performance may not precisely track 2x of the Daily performance of the Index.  This tracking error may result from the investment strategy used, costs related to the use of Swaps, liquidity of the market and fees and expenses, and the correlation between the performance of the Product and the two times (2x) Daily performance of the Index may be reduced.  The Manager will monitor and seek to manage such risk in minimising tracking error. There can be no assurance of exact or identical replication of the leveraged performance of the Index at any time.

  • Prices of the Product may be more volatile than conventional ETFs because of the daily rebalancing activities and the leverage effect.

  • The Product may be terminated early under certain circumstances, for example, where there is no market maker, the Index is no longer available for benchmarking or if the size of the Product falls below USD10 million. Investors may not be able to recover their investments and suffer a loss when the Product is terminated.

Please note that the above listed investment risks are not exhaustive and investors should read the Prospectus in detail before making any investment decision.


  • FUND INFORMATION
  • PERFORMANCE
  • TRACKING ERROR
  • HOLDINGS
  • DISTRIBUTION
  • FUND LITERATURE
  • DISTRIBUTORS
  • RELATED

FUND INFORMATION

KEY INFORMATION
Fund Manager
Bosera Asset Management (International) Co., Limited
Trustee
Cititrust Limited
Outstanding Units
58,800,000.00
Listing Date
12 May 2022
Base Currency
Hong Kong dollars (HKD)
Management Fee
1.48%
Benchmark Index
ChiNext Index (HKD)(CNH)
Index Provider
Shenzhen Securities Information Co., Ltd
Benchmark Level Type
Price Return
Total Return Index
ChiNext Index
Price Return Index
ChiNext Index
Financial Year End
31 December
Participating Dealers7
Citigroup Global Markets Asia Limited
China International Capital Corporation Hong Kong Securities Limited
Mirae Asset Securities (HK) Limited
Haitong International Securities Company Limited
Goldman Sachs (Asia) Securities Limited
Market Makers (HKD Counter) 8
Link to latest list of market makers
INTRA-DAY ESTIMATED NAV1,2,3 & MARKET PRICE4
DateTimeHKD
Intra-day Estimated NAV Per Unit06/02/202509:34 am3.5658
Intra-day Market Priced05/02/202504:08 pm3.5580
Date
Intra-day Estimated NAV Per Unit06/02/2025
Intra-day Market Priced05/02/2025
d=at least 15 minutes delay Hong Kong Time: 09:35 am
FUND OBJECTIVE
The investment objective of the Product is to provide investment results that, before fees and expenses, closely correspond to twice (2x) the Daily performance of the Index. The Product does not seek to achieve its stated investment objective over a period of time greater than one day.
TRADING INFORMATION
Stock Code07234
Trading CurrencyHong Kong dollars (HKD)
Primary market - Application Unit SizeMinimum 100,000 Units (or multiples thereof)
Secondary market - Trading Board Lot Size100 Units
ISIN CodeHK0000828696
Bloomberg Ticker7234 HK
SEDOL CodeBM9GWC8
Stock Code 07234
Trading CurrencyHong Kong dollars (HKD)
Primary market - Application Unit SizeMinimum 100,000 Units (or multiples thereof)
Secondary market - Trading Board Lot Size100 Units
ISIN CodeHK0000828696
Bloomberg Ticker7234 HK
SEDOL CodeBM9GWC8
MARKET INFORMATION5
DateLastChange%Change
Official NAV per Unit in HKD05/02/2025HKD 3.5534-0.0261-0.73
Closing Price for HKD Traded Unit05/02/2025HKD 3.5580-0.1260-3.42
Date
Official NAV per Unit in HKD05/02/2025
Closing Price for HKD Traded Unit05/02/2025

1. IOPV calculations and delayed market data as shown on the website of Bosera Asset Management (International) Co., Limited (http://www.bosera.com.hk) (the “data”) are provided by ICE Data Indices, see ICE Terms of Use, and are updated during HKEx trading hours. Powered by Factset.
2. IOPV is indicative and for reference purposes only. The Fund is not sponsored, endorsed, sold or marketed by ICE Data Indices, LLC, its affiliates (“ICE Data”) and ICE Data or its respective third party suppliers make no express or implied warranties, and hereby expressly disclaim all warranties of merchantability or fitness for a particular purpose with respect to the iNAV, IOPV, fund or any fund data included therein. In no event shall ICE Data have any liability for any special, punitive, direct, indirect, or consequential damages (including lost profits), even if notified of the possibility of such damages. You acknowledge that the data is provided for information only and should not be relied upon for any purpose.
3. HKEx information services limited, its holding companies and/or any subsidiaries of such holding companies endeavor to ensure the accuracy and reliability of the information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
4. The Intra-day Market Price is provided on a 15-minute delayed basis by ICE Data Indices.
5. Change is calculated on NAV to NAV basis in HKD and assumes dividend will not be reinvested. Change of the official NAV per Unit in RMB and change of the NAV per Unit in HKD indicate the change of the NAV per Unit since previous business day where both the SEHK and underlying A-shares market are opened for normal trading (the "Dealing Day"). Please refer to the Prospectus for more information on determination of NAV
6. Index returns are provided for illustrative purpose only and are not indicative of future performance. Management fees, transaction costs or other expenses are not reflected in index returns.
7. Additional participating dealer(s) will be appointed from time to time.
8. Please refer to HKEx website for the most updated information. Additional Market Maker(s) will be appointed from time to time.

Index Provider Disclaimer:
 The Index is compiled, maintained and operated by Shenzhen Securities Information Company Limited (‘SSICL’), delegated and authorized by Shenzhen Stock Exchange. The index department of SSICL periodically reviews constituents’ representativeness and determines whether to change any constituent according to the review.  The Index is an asset owned by Shenzhen Stock Exchange.  The Shenzhen Stock Exchange and the SSICL are independent of the Manager and the Investment Adviser.
Bosera SZSE ChiNext Daily (2x) Leveraged Product is not in any way endorsed, sold, sponsored or promoted by the Shenzhen Stock Exchange, SSICL or the SEHK. The Shenzhen Stock Exchange, SSICL or the SEHK makes no warranty or representation whatsoever, expressly or impliedly, as to the results of the use of the ChiNext Index. The ChiNext Index is calculated by or on behalf of SSICL, which will adopt all necessary measures to ensure the accuracy of the ChiNext Index. However, the Shenzhen Stock Exchange, the SSICL and the SEHK shall not be liable (whether in negligence or otherwise) to any person for any error in the ChiNext Index and shall not be under any obligation to advise any person or any error therein. The ChiNext Index is owned by the Shenzhen Stock Exchange.
 The above is a brief summary of the basic information, selection criteria, selection methodology and maintenance of the ChiNext Index as at the date of this Prospectus. Such information is subject to revision from time to time by the Shenzhen Stock Exchange and the SSICL. Before making investment decisions, investors should refer to the website of the Shenzhen Stock Exchange (www.szse.cn) and the Index Department of SSICL (www.cnindex.com.cn) for the latest version of such information.

Disclaimer:
This website is owned and managed by Bosera Asset Management (International) Co., Limited (“BOSERA”). BOSERA reserves the right to change, modify, add or delete, any content and the terms & conditions of use of this website without notice. Users are advised to periodically review the contents of this website to be familiar with any modifications.
The performance figures contained on this website are for informational purposes only. Past performance is not indicative of future performance. Investment involves risks and the Product's NAV per unit may rise as well as fall. Persons interested in investing in the Product should read the relevant fund offering documents (including the full text of the risk factors stated therein) in detail before making any investment decision.
This website is prepared by BOSERA and has not been reviewed by the Securities and Futures Commission.


PERFORMANCE

1Y
博時中國創業板每日槓桿(2x)產品(價格回報)創業板指數(港幣)(CNH)(價格回報)創業板指數(港幣)(CNH)(2x)(價格回報)
博時中國創業板指數每日槓桿(2x)產品
日期單位淨值每日變化累積單位淨值
07/02/20253.93440.18403.9344
06/02/20253.75040.19703.7504
05/02/20253.5534-0.02613.5534
27/01/20253.5795-0.22493.5795
24/01/20253.80440.13153.8044
23/01/20253.6729-0.02743.6729
22/01/20253.7003-0.03763.7003
21/01/20253.73790.06423.7379
20/01/20253.67370.14383.6737
17/01/20253.52990.05413.5299
日期 單位淨值
07/02/20253.9344
06/02/20253.7504
05/02/20253.5534
27/01/20253.5795
24/01/20253.8044
23/01/20253.6729
22/01/20253.7003
21/01/20253.7379
20/01/20253.6737
17/01/20253.5299
由於子基金乃新成立,故無充分數據為投資者提供過往表現的有用指標。
累積表現 % (以類別貨幣計算)截至 31/01/2025
基金類別年初至今3個月1年3年5年成立至今
創業板指數(港幣)(CNH)(價格回報)-2.60-6.2629.23---19.05
創業板指數(港幣)(CNH)槓桿(2x)(價格回報)*-5.78-14.2545.96---47.82
博時中國創業板槓桿(2x)產品 (價格回報)-6.41-16.0135.29---55.26
基金類別 年初至今
創業板指數(港幣)(CNH)(價格回報)-2.60
創業板指數(港幣)(CNH)槓桿(2x)(價格回報)*-5.78
博時中國創業板槓桿(2x)產品 (價格回報)-6.41
累積表現由2022年05月12日成立以來計算。
年度表現 % (以類別貨幣計算)截至 31/01/2025
基金類別2025202420232022^2021
創業板指數(港幣)(CNH)(價格回報)-2.608.97-20.67--
創業板指數(港幣)(CNH)槓桿(2x)(價格回報)*-5.783.63-39.39--
博時中國創業板槓桿(2x)產品 (價格回報)-6.41-4.11-42.61--
基金類別 2025
創業板指數(港幣)(CNH)(價格回報)-2.60
創業板指數(港幣)(CNH)槓桿(2x)(價格回報)*-5.78
博時中國創業板槓桿(2x)產品 (價格回報)-6.41
^2022基金年度表現是從2022年05月12日(基金成立日)開始計算。
基金表現以資產淨值對資產淨值計算(當中已將股息再做投資(如有))。

資料來源:博時基金(國際)有限公司
過往的業績並不代表將來的表現。投資者可能無法取回原本投資金額。
表現模擬分析
  • 投資者應瞭解本槓桿產品的投資目標是提供相對於指數接近兩倍的每日的槓桿投資業績。槓桿產品每單位價值每日進行重新調整以達至其投資目標。當投資者持有產品少於一個交易日或過夜,進行每日重新調整會導致未能追蹤指數的多倍回報。
  • 下列為模擬表配圖表,使投資者能根據過往數據選擇特定時期模擬產品表現。假設投資者於整個模擬時期持有槓桿產品。槓桿產品表現以每基金單位計算。槓桿產品表現未必能夠反映投資者可取得的回報,因為槓桿產品的折價或溢價,或交易成本未有包括在計算內。
1Y
博時中國創業板每日槓桿(2x)產品(價格回報)創業板指數(港幣)(CNH)(價格回報)創業板指數(港幣)(CNH)(2x)(價格回報)
模擬結果
博時中國創業板每日槓桿(2x)產品(價格回報)*22.61%
創業板指數(港幣)(CNH)(價格回報)22.63%
創業板指數(港幣)(CNH)(2x)(價格回報)*31.98%

* 數字只作示範用途,並不代表實際可能獲得的回報。

指數提供者免責聲明:
指數由深圳證券交易所委托並授權深圳證券信息有限公司(”深證信息”)編制、維護及營運。深圳交易所指數部門定期檢視成份股的代表性,並根據檢審查結果決定是否對成份股作出變動。指數為深圳證券交易所擁有的資產。深圳證券交易所及深交所獨立於基金經理。
博時中國創業板指數每日槓桿(2x)產品並非由深圳證券交易所、深交所或港交所以任何形式核淮、出售、擔保或宣傳。深圳證券交易所、深交所或港交所對於使用中國創業板指數的業績不會作出明示或隱含保證或聲明。中國創業板指數由深交所或其代表結算,將採取一切所需措施確保中國創業板指數的準確性。然而,深圳證券交易所,深交所及港交所不會承擔(不論是否疏忽或其他)任何人在中國創業板造成的錯誤,亦不需負上任何責任向任何人或任何錯誤提供意見。中國創業板指數為深圳證券交易所擁有。
以上為中國創業板指數於本招股書發行日之基本信息、篩選要求、篩選方法及維護概要。該信息受限於由深圳證券交易所定期修改。在作出投資決定前,投資者應參閱深圳證券交易所網站(www.szse.cn)及深交所指數部門網站(www.cnindex.com.cn) 取得該信息的最新版本。

免責聲明:
本網站由博時基金(國際)資產管理有限公司(「博時基金」)擁有及管理。博時基金保留本網站無須發佈通知下更改、修改、增加及/或刪除任何內容及條款及細則之權利。用戶可定期查閱本網站了解任何改動。
網站內刊登之基金表現數據只作資訊性用途。基金過往業績並不代表將來表現。投資涉及風險,產品的價值可能會非常波動。有興趣投資本產品的投資者應在作出任何投資決定前詳細閱讀基金文件(包括在內的風險因素全文)。
本網站由博時基金編制,所載之內容並未經證監會審閱。

TRACKING ERROR

追蹤差異/追蹤誤差
槓桿產品的投資目標是提供相關指數每日表現雙重(2x)表玩的投資業績,因此在計算每日追蹤轉變度時,所追蹤指數的單日表現將乘以槓桿因素(2x)作比較。
本槓桿產品的表現根據基金單位資產淨值對資產淨值計算,其股息將作滾存投資。
跟蹤偏離度截至 27/01/2025
每日追蹤偏離度指槓桿產品的每日回報與相關指數的每日表現兩倍(2x)之間的差異。
基金上市日期: 12/05/2022滾動一年實際平均每日跟蹤偏離度 -0.03%2025年度實際平均每日跟蹤偏離度 -0.04%2024年度實際平均每日跟蹤偏離度 -0.03%2024年度實際平均每日跟蹤偏離度 -0.03%2024年度實際平均每日跟蹤偏離度 -0.03%2024年度實際平均每日跟蹤偏離度 -0.04%2024年度實際平均每日跟蹤偏離度 -0.04%2024年度實際平均每日跟蹤偏離度 -0.04%2024年度實際平均每日跟蹤偏離度 -0.04%2024年度實際平均每日跟蹤偏離度 -0.04%2024年度實際平均每日跟蹤偏離度 -0.04%2024年度實際平均每日跟蹤偏離度 -0.04%2024年度實際平均每日跟蹤偏離度 -0.04%2023年度實際平均每日跟蹤偏離度 -0.02%2023年度實際平均每日跟蹤偏離度 -0.02%
跟蹤誤差截至 27/01/2025
追蹤誤差是量度槓桿產品追蹤其相關指數每日表現兩倍(2x)的一致性,以每日差異的波幅顯示(以標準差計算)。
基金上市日期: 12/05/20221年滾動跟蹤誤差^ 1.81%
^追蹤誤差以每日追蹤偏離度的標準差衡量。標準差根據滾動一年期間的每日追蹤偏離度計算。

指數提供者免責聲明:
指數由深圳證券交易所委托並授權深圳證券信息有限公司(”深證信息”)編制、維護及營運。深圳交易所指數部門定期檢視成份股的代表性,並根據檢審查結果決定是否對成份股作出變動。指數為深圳證券交易所擁有的資產。深圳證券交易所及深交所獨立於基金經理。
博時中國創業板指數每日槓桿(2x)產品並非由深圳證券交易所、深交所或港交所以任何形式核淮、出售、擔保或宣傳。深圳證券交易所、深交所或港交所對於使用中國創業板指數的業績不會作出明示或隱含保證或聲明。中國創業板指數由深交所或其代表結算,將採取一切所需措施確保中國創業板指數的準確性。然而,深圳證券交易所,深交所及港交所不會承擔(不論是否疏忽或其他)任何人在中國創業板造成的錯誤,亦不需負上任何責任向任何人或任何錯誤提供意見。中國創業板指數為深圳證券交易所擁有。
以上為中國創業板指數於本招股書發行日之基本信息、篩選要求、篩選方法及維護概要。該信息受限於由深圳證券交易所定期修改。在作出投資決定前,投資者應參閱深圳證券交易所網站(www.szse.cn)及深交所指數部門網站(www.cnindex.com.cn) 取得該信息的最新版本。

免責聲明:
本網站由博時基金(國際)資產管理有限公司(「博時基金」)擁有及管理。博時基金保留本網站無須發佈通知下更改、修改、增加及/或刪除任何內容及條款及細則之權利。用戶可定期查閱本網站了解任何改動。
網站內刊登之基金表現數據只作資訊性用途。基金過往業績並不代表將來表現。投資涉及風險,產品的價值可能會非常波動。有興趣投資本產品的投資者應在作出任何投資決定前詳細閱讀基金文件(包括在內的風險因素全文)。

本網站由博時基金編制,所載之內容並未經證監會審閱。


HOLDINGS

產品持倉截至 07/02/2025
資產淨值總額 (港元)
(被視為資產淨值總額(港元))1
掉期合约總值 (港元)掉期合約風險承擔 (%)2
231,344,801.16
(231,212,048.26)
462,130,088.94199.87%
1被視為資產淨值總額包括(i)即日重新調整;及(ii)即日增設/贖回申請所產生的交易活動。
2掉期合約投資=期貨合約總值/被視為資產淨值總額。
掉期合約持倉截至 07/02/2025
掉期合約名稱數量
ChiNext Index (SWAP)226,900
有關對手方的更多信息,請訪問Citigroup Global Markets Limited (https://icg.citi.com/icghome )、Goldman Sachs International(https://www.goldmansachs.com/)及CICC Financial Trading Limited(https://www.cicc.com/)的公司網頁 。
衍生工具對手方詳情截至 07/02/2025
對手方名稱風險承擔總額風險承擔淨額
CICC Financial Trading Limited97.88%2.88%
Citigroup Global Markets Limited90.72%5.62%
Goldman Sachs International11.28%0.78%
對手方名稱 風險承擔總額
CICC Financial Trading Limited97.88%
Citigroup Global Markets Limited90.72%
Goldman Sachs International11.28%
  • 1
  • 10 條/頁
有關對手方的更多信息,請訪問Citigroup Global Markets Limited (https://icg.citi.com/icghome )、Goldman Sachs International(https://www.goldmansachs.com/)及CICC Financial Trading Limited(https://www.cicc.com/)的公司網頁 。
抵押品截至 07/02/2025
前十名抵押品截至 07/02/2025
投資組合比重(%)
港币现金100.00
投資組合 比重(%)
港币现金100.00
  • 1
  • 10 條/頁
投資組合詳情截至 07/02/2025
投資組合比重(%)
現金及現金等價物76.50
BOSERA HKD MONEY MARKET ETF23.50
  • 1
  • 10 條/頁
投資組合 比重(%)
現金及現金等價物76.50
BOSERA HKD MONEY MARKET ETF23.50
  • 1
  • 10 條/頁
由於四捨五入及不會顯示持股少於1%,所有”投資組合詳情”所顯示的總和未必等於100%。關於不到1%的證券持有資訊,因無法得到廣泛使用,可能不包括在列表中。

基金持倉或有變化。鑒於四捨五入,持股列表所示的分配總和未必等如100%。本文件提供的數據為過往數據,只限作參考用途,不可作為未來表現的指引。

指數提供者免責聲明:
指數由深圳證券交易所委托並授權深圳證券信息有限公司(”深證信息”)編制、維護及營運。深圳交易所指數部門定期檢視成份股的代表性,並根據檢審查結果決定是否對成份股作出變動。指數為深圳證券交易所擁有的資產。深圳證券交易所及深交所獨立於基金經理。
博時中國創業板指數每日槓桿(2x)產品並非由深圳證券交易所、深交所或港交所以任何形式核淮、出售、擔保或宣傳。深圳證券交易所、深交所或港交所對於使用中國創業板指數的業績不會作出明示或隱含保證或聲明。中國創業板指數由深交所或其代表結算,將採取一切所需措施確保中國創業板指數的準確性。然而,深圳證券交易所,深交所及港交所不會承擔(不論是否疏忽或其他)任何人在中國創業板造成的錯誤,亦不需負上任何責任向任何人或任何錯誤提供意見。中國創業板指數為深圳證券交易所擁有。
以上為中國創業板指數於本招股書發行日之基本信息、篩選要求、篩選方法及維護概要。該信息受限於由深圳證券交易所定期修改。在作出投資決定前,投資者應參閱深圳證券交易所網站(www.szse.cn)及深交所指數部門網站(www.cnindex.com.cn) 取得該信息的最新版本。

免責聲明:
本網站由博時基金(國際)資產管理有限公司(「博時基金」)擁有及管理。博時基金保留本網站無須發佈通知下更改、修改、增加及/或刪除任何內容及條款及細則之權利。用戶可定期查閱本網站了解任何改動。
網站內刊登之基金表現數據只作資訊性用途。基金過往業績並不代表將來表現。投資涉及風險,產品的價值可能會非常波動。有興趣投資本產品的投資者應在作出任何投資決定前詳細閱讀基金文件(包括在內的風險因素全文)。
本網站由博時基金編制,所載之內容並未經證監會審閱。


DISTRIBUTION

派息記錄
Bosera SZSE ChiNext Daily (2x) Leveraged Product
類別基金記錄日除息日派息日每單位獲分派收益股息從每月淨可分派收益中派發股息從資本中派發

無此資料

類別基金 記錄日

無此資料

· 基金經理可酌情決定以資本支付分派。基金經理亦可酌情決定以總收入支付分派,以致可供產品支付分派的可分派收入有所增加,因此,產品可能實際上以資本支付分派。

· 任何涉及以產品的資本支付或實際以上品支付的分派可能導致每單位資產淨值即時減少,並妁減少單位持有人的資本增值。

* 「可分派淨收益」指應佔相關股份類別的投資淨收益(即股息收益及利息收入減去費用及開支),亦可包括基於未審計管理帳戶的淨收益(如有)。然而,「可分派淨收益」不包括淨收益。
「以可分派淨收益支付」及「收益以資本支付」的數據只作參考用途。請參閱官方每股收益信息。
警告:請注意正派息率並不代表正回報。投資者不可單箊上述列表內的資料而作出任何投資決定。投資涉及風險。請參閱有關子基金的說明書(包括產品資料概要),以取得更詳盡資料包括風險因素。
所有貨幣單位為港元(HKD)。所有日期為格林威治標準時間GMT+8 時區。

指數提供者免責聲明:
指數由深圳證券交易所委托並授權深圳證券信息有限公司(”深證信息”)編制、維護及營運。深圳交易所指數部門定期檢視成份股的代表性,並根據檢審查結果決定是否對成份股作出變動。指數為深圳證券交易所擁有的資產。深圳證券交易所及深交所獨立於基金經理。
博時中國創業板指數每日槓桿(2x)產品並非由深圳證券交易所、深交所或港交所以任何形式核淮、出售、擔保或宣傳。深圳證券交易所、深交所或港交所對於使用中國創業板指數的業績不會作出明示或隱含保證或聲明。中國創業板指數由深交所或其代表結算,將採取一切所需措施確保中國創業板指數的準確性。然而,深圳證券交易所,深交所及港交所不會承擔(不論是否疏忽或其他)任何人在中國創業板造成的錯誤,亦不需負上任何責任向任何人或任何錯誤提供意見。中國創業板指數為深圳證券交易所擁有。
以上為中國創業板指數於本招股書發行日之基本信息、篩選要求、篩選方法及維護概要。該信息受限於由深圳證券交易所定期修改。在作出投資決定前,投資者應參閱深圳證券交易所網站(www.szse.cn)及深交所指數部門網站(www.cnindex.com.cn) 取得該信息的最新版本。

免責聲明:
本網站由博時基金(國際)資產管理有限公司(「博時基金」)擁有及管理。博時基金保留本網站無須發佈通知下更改、修改、增加及/或刪除任何內容及條款及細則之權利。用戶可定期查閱本網站了解任何改動。
網站內刊登之基金表現數據只作資訊性用途。基金過往業績並不代表將來表現。投資涉及風險,產品的價值可能會非常波動。有興趣投資本產品的投資者應在作出任何投資決定前詳細閱讀基金文件(包括在內的風險因素全文)。
本網站由博時基金編制,所載之內容並未經證監會審閱。


DISTRIBUTORS

分銷商

無此資料

欲進一步了解我們的基金產品
請致電或發送電郵至博時國際專線

  • (852)2537 6658
  • HKSales@bosera.com
  • 香港中環康樂廣場1號怡和大廈4109室